<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (T2DM) and <z:hpo ids='HP_0001513'>obesity</z:hpo> are associated with <z:chebi fb="131" ids="25107">magnesium</z:chebi> deficiency </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to determine whether the presence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the degree of metabolic control are related to low serum <z:chebi fb="131" ids="25107">magnesium</z:chebi> levels in <z:mp ids='MP_0001261'>obese</z:mp> individuals </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A) Case-control study: 200 <z:mp ids='MP_0001261'>obese</z:mp> subjects [50 with T2DM (cases) and 150 without <z:mp ids='MP_0002055'>diabetes</z:mp> (controls)] prospectively recruited </plain></SENT>
<SENT sid="3" pm="."><plain>B) Interventional study: the effect of bariatric surgery on serum <z:chebi fb="131" ids="25107">magnesium</z:chebi> levels was examined in a subset of 120 <z:mp ids='MP_0001261'>obese</z:mp> subjects (40 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 80 without <z:mp ids='MP_0002055'>diabetes</z:mp>) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Type 2 diabetic patients showed lower serum <z:chebi fb="131" ids="25107">magnesium</z:chebi> levels [0.75±0.07 vs. 0.81±0.06 mmol/L; mean difference -0.06 (95% CI -0.09 to -0.04); p&lt;0.001] than non-diabetic patients </plain></SENT>
<SENT sid="5" pm="."><plain>Forty-eight percent of diabetic subjects, but only 15% of non-diabetic subjects showed a serum <z:chebi fb="131" ids="25107">magnesium</z:chebi> concentration lower than 0.75 mmol/L </plain></SENT>
<SENT sid="6" pm="."><plain>Significant negative correlations between <z:chebi fb="131" ids="25107">magnesium</z:chebi> and fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA1c, HOMA-IR, and BMI were detected </plain></SENT>
<SENT sid="7" pm="."><plain>Multiple linear regression analysis showed that fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and HbA1c independently predicted serum <z:chebi fb="131" ids="25107">magnesium</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>After bariatric surgery serum <z:chebi fb="131" ids="25107">magnesium</z:chebi> increased only in those patients in whom <z:mp ids='MP_0002055'>diabetes</z:mp> was resolved, but remain unchanged in those who not, without difference in loss weight between groups </plain></SENT>
<SENT sid="9" pm="."><plain>Changes in serum <z:chebi fb="131" ids="25107">magnesium</z:chebi> negatively correlated with changes in fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and HbA1c </plain></SENT>
<SENT sid="10" pm="."><plain>Absolute changes in HbA1c independently predicted <z:chebi fb="131" ids="25107">magnesium</z:chebi> changes in the multiple linear regression analysis </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Our results provide evidence that the presence of <z:mp ids='MP_0002055'>diabetes</z:mp> and the degree of metabolic control are essential in accounting for the lower levels of <z:chebi fb="131" ids="25107">magnesium</z:chebi> that exist in <z:mp ids='MP_0001261'>obese</z:mp> subjects </plain></SENT>
</text></document>